Table 1 Clinical data of the anti-Yo PCD cohort
Patient | Age (years) | Diagnosis | Grade | Delay between onset of symptoms and diagnosis of cancer (months) | Sample age (years) |
|---|---|---|---|---|---|
1 | 54.8 | HGSC | IV | 1.4 | 5.1 |
2 | 70.5 | HGSC | IA | 1.6 | 7.2 |
3 | 54.7 | HGSC | IV | -54.8 | 18.6 |
4 | 66.7 | HGSC | IV | -16.3 | 12.4 |
5 | 50.2 | HGSC | IIIC | 5.1 | 14.1 |
6 | 72 | HGSC | IV | 2.5 | 12.2 |
7 | 62.8 | HGSC | IIIC | 2.6 | 13.5 |
8 | 80 | HGSC | IIIC | -28.4 | 16.2 |
9 | 81.4 | CCC | IA | -72.4 | 11.6 |
10 | 55.2 | CS | IIIC | -3.5 | 4.4 |
11 | 62.3 | HGSC | IIIC | 1.6 | 9.6 |
12 | 51.2 | HGSC | IIIA | 6 | 1.4 |
